Atlasxomics Inc.
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- atlasxomics.com
- Founded
- 2020
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $57,000 |
| FY2023 | $80,000 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| The Johns Hopkins University | P30AG073104 | $120,000 |
Similar vendors
About the company
Atlasxomics Inc. is a biotechnology company specializing in spatial multi-omics technologies, with a focus on developing innovative platforms for advanced genomic and epigenomic research. The company's proprietary Deterministic Barcoding in Tissue for Spatial Omics Sequencing (DBiT-seq) platform enables researchers to map molecular interactions within tissue samples at high resolution. Through federal contract and grant awards, Atlasxomics provides cutting-edge laboratory services, hardware starter kits, sample optimization kits, and spatial sequencing technologies primarily to biomedical research agencies, with a particular emphasis on supporting advanced research in genomics, cancer studies, and complex disease investigations.
The company has secured multiple federal contract awards from civilian agencies, predominantly the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the National Cancer Institute. These contracts, ranging from $13,500 to $52,500, involve purchasing hardware starter kits, sample optimization kits, and spatial ATAC-seq kits for scientific research purposes. The contracts are primarily firm fixed-price purchase orders with no specific set-aside designations. Atlasxomics has delivered laboratory and testing services focused on ATAC sequencing analysis, involving the processing of tissue samples to support genomic and epigenomic research. The contracts demonstrate the company's capability to provide specialized scientific equipment and services tailored to the specific research needs of federal research institutions.
Atlasxomics has been awarded multiple federal grants from agencies including the National Human Genome Research Institute and the National Cancer Institute, totaling significant funding for research and development projects. These grants, primarily Small Business Innovation Research (SBIR) awards, focus on developing advanced spatial biology technologies. Key grant objectives include commercializing platforms for spatial co-profiling of transcriptome and epigenome, developing user-friendly epigenomic chips adaptable to automation workflows, and creating innovative multi-omics analysis tools for investigating disease mechanisms. The grants, ranging from $399,929 to $800,000, support the company's efforts to develop comprehensive spatial biology technologies that enable researchers to map gene expression, chromatin accessibility, and protein levels within intact tissue samples, with particular applications in cancer research, neurodegenerative diseases, and complex biological systems.
Quick answers
Is Atlasxomics Inc. registered in SAM.gov?
Atlasxomics Inc.'s SAM.gov registration expired on October 10, 2026.
What is Atlasxomics Inc.'s CAGE code?
Atlasxomics Inc.'s CAGE code is 8MSC0, and its Unique Entity ID (UEI) is LVJJTHPGMQJ9.
How much has Atlasxomics Inc. received in federal contracts?
Federal contracts obligated $137,000 to Atlasxomics Inc. in fiscal years 2023 through 2027.
What is Atlasxomics Inc.'s most recent federal award?
Atlasxomics Inc.'s most recent federal contract award is Atlasxomics INC.:1354803 [24-003617] (75N92B24P00107), from National Insititue of Arthritis and Musculoskeletal and Skin Diseases (NIH), on August 13, 2024.
On GovTribe
See Atlasxomics Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors